Masakazu Abé

1.2k total citations
65 papers, 797 citations indexed

About

Masakazu Abé is a scholar working on Surgery, Physiology and Oncology. According to data from OpenAlex, Masakazu Abé has authored 65 papers receiving a total of 797 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Surgery, 13 papers in Physiology and 11 papers in Oncology. Recurrent topics in Masakazu Abé's work include Nausea and vomiting management (18 papers), Anesthesia and Pain Management (11 papers) and Chemotherapy-induced organ toxicity mitigation (8 papers). Masakazu Abé is often cited by papers focused on Nausea and vomiting management (18 papers), Anesthesia and Pain Management (11 papers) and Chemotherapy-induced organ toxicity mitigation (8 papers). Masakazu Abé collaborates with scholars based in Japan, United States and Italy. Masakazu Abé's co-authors include Munetaka Takekuma, Yasuyuki Hirashima, Aki Tanaka, Nobutaka Takahashi, Shiho Kuji, Nobuhiro Kado, Miho Takahashi, Tsuyoshi Sugiura, Shingo Saito and Kanemitsu Shirasuna and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and The Lancet Oncology.

In The Last Decade

Masakazu Abé

58 papers receiving 771 citations

Peers

Masakazu Abé

SURGE

PHYSI

ONCOL

PRM

Yuan James Rao United States

Kyoung Sook Won South Korea

Antonella Barreca Italy

E. G. Wood United States

Alexander J. Lin United States

Kuo‐Yang Yen Taiwan

Ho‐Chun Song South Korea

Renato Patrone Italy

Mayur Virarkar United States

Ovidiu Simion Cotoi Romania

Yuan James Rao United States

Masakazu Abé

252 ×0.7

SURGE

48 ×0.3

PHYSI

237 ×1.5

ONCOL

162 ×1.5

192 ×1.9

PRM

Citations per year, relative to Masakazu Abé Masakazu Abé (= 1×) peers Yuan James Rao

Countries citing papers authored by Masakazu Abé

Since Specialization

Citations

This map shows the geographic impact of Masakazu Abé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masakazu Abé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masakazu Abé more than expected).

Fields of papers citing papers by Masakazu Abé

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masakazu Abé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masakazu Abé. The network helps show where Masakazu Abé may publish in the future.

Co-authorship network of co-authors of Masakazu Abé

This figure shows the co-authorship network connecting the top 25 collaborators of Masakazu Abé. A scholar is included among the top collaborators of Masakazu Abé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masakazu Abé. Masakazu Abé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Abé, Masakazu, Shigekatsu Maekawa, Akiko Yashima‐Abo, et al.. (2024). The Clinical Validity of Urinary Pellet DNA Monitoring for the Diagnosis of Recurrent Bladder Cancer. Journal of Molecular Diagnostics. 26(4). 278–291. 4 indexed citations

Abé, Masakazu, et al.. (2024). Shared decision-making in patients with gynecological cancer and healthcare professionals: a cross-sectional observational study in Japan. Journal of Gynecologic Oncology. 36(3). e47–e47.

Abé, Masakazu, Noriyuki Sasaki, Akiko Yashima‐Abo, et al.. (2023). Postoperative recurrence detection using individualized circulating tumor DNA in upper tract urothelial carcinoma. Cancer Science. 115(2). 529–539. 11 indexed citations

Abé, Masakazu, et al.. (2023). EP404/#379 Discrepancies between patient and healthcare professional values in managing side effects of gynecologic anticancer drug therapy in Japan. A238.3–A239. 1 indexed citations

Abé, Masakazu, et al.. (2023). Evaluation of the initial timing of infection control pharmacist-driven audit and monitoring of vancomycin therapy in patients with infectious diseases: A retrospective observational study. PLoS ONE. 18(8). e0291096–e0291096.

Abé, Masakazu, Takuhiro Yamaguchi, Yukiyoshi Fujita, et al.. (2023). Efficacy of Olanzapine in Addition to Standard Triplet Antiemetic Therapy for Cisplatin-Based Chemotherapy. JAMA Network Open. 6(5). e2310894–e2310894. 3 indexed citations

Abé, Masakazu, Hirotoshi Iihara, & Kenjiro Aogi. (2023). Fosnetupitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Short Review and Clinical Perspective. Advances in Therapy. 40(5). 1913–1925. 3 indexed citations

Iihara, Hirotoshi, Mototsugu Shimokawa, Hironobu Hashimoto, et al.. (2022). Study protocol for a double-blind, comparative, randomised Japanese trial of triplet standard antiemetic therapies with or without 5 mg olanzapine to prevent chemotherapy-induced nausea and vomiting for patients with breast cancer treated with an anthracycline/cyclophosphamide regimen (JTOP-B). BMJ Open. 12(3). e058755–e058755.

Iwaya, Takeshi, Fumitaka Endo, Masashi Idogawa, et al.. (2021). Early dynamics of circulating tumor DNA predict chemotherapy responses for patients with esophageal cancer. Carcinogenesis. 42(10). 1239–1249. 19 indexed citations

10.

Abé, Masakazu, et al.. (2020). Attempts to Promote IEEE802.11ah in Japan. Marine Engineering. 55(2). 205–210.

11.

Abé, Masakazu, Daiki Ikarashi, Renpei Kato, et al.. (2020). Prognostic outcomes and safety in patients treated with pembrolizumab for advanced urothelial carcinoma: experience in real-world clinical practice. International Journal of Clinical Oncology. 25(5). 899–905. 37 indexed citations

12.

Hashimoto, Hironobu, Masakazu Abé, Osamu Tokuyama, et al.. (2019). Olanzapine 5 mg plus standard antiemetic therapy for the prevention of chemotherapy-induced nausea and vomiting (J-FORCE): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet Oncology. 21(2). 242–249. 114 indexed citations

13.

Nishio, Shin, Munetaka Takekuma, Satoshi Takeuchi, et al.. (2017). Phase 1 study of veliparib with carboplatin and weekly paclitaxel in Japanese patients with newly diagnosed ovarian cancer. Cancer Science. 108(11). 2213–2220. 21 indexed citations

14.

Abé, Masakazu, Yasuyuki Hirashima, Nobuhiro Kado, et al.. (2015). Efficacy and safety of olanzapine combined with aprepitant, palonosetron, and dexamethasone for preventing nausea and vomiting induced by cisplatin-based chemotherapy in gynecological cancer: KCOG-G1301 phase II trial. Supportive Care in Cancer. 24(2). 675–682. 54 indexed citations

15.

Takeshima, Nobuhiro, Maki Matoda, Masakazu Abé, et al.. (2014). Efficacy and safety of triple therapy with aprepitant, palonosetron, and dexamethasone for preventing nausea and vomiting induced by cisplatin-based chemotherapy for gynecological cancer: KCOG-G1003 phase II trial. Supportive Care in Cancer. 22(11). 2891–2898. 8 indexed citations

16.

Abé, Masakazu, et al.. (2013). Clinical research of olanzapine for prevention of chemotherapy-induced nausea and vomiting resistant to standard antiemetic treatment for highly emetogenic chemotherapy. Palliative Care Research. 8(1). 127–134. 2 indexed citations

17.

Abe, Shinji, Yasushi Tsuji, Takahiro Tsushima, et al.. (2010). Efficacy and Feasibility of Combination Chemotherapy with S-1 and Cisplatin (2 Weeks Regimen) for Advanced Gastric Cancer. Japanese Journal of Clinical Oncology. 40(4). 302–306. 2 indexed citations

18.

Tabata, Nobuko, et al.. (1999). Paraquat myopathy: report on two suicide cases. Forensic Science International. 100(1-2). 117–126. 14 indexed citations

19.

Kawai, H, Kenji Yokoi, M. Akaike, et al.. (1995). Graves' disease in HTLV-I carriers. Journal of Molecular Medicine. 73(2). 85–88. 13 indexed citations

20.

Tsuzuki, Kayo, Ryo Fukatsu, Kôichi Kimura, et al.. (1994). Immunohistochemical evidence for amyloid β in rat soleus muscle in chloroquine-induced myopathy. Neuroscience Letters. 182(2). 151–154. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact